Page 985 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 985

960                                        CHAPTER 7



  VetBooks.ir  or congestive heart failure, mannitol cannot move  Sodium bicarbonate
                                                          Sodium bicarbonate has been successfully used in
           into cells and is retained within the extracellular
           fluid. Water moves out of cells into the extracellular
                                                          of urine diminishes renal retention of myoglobin.
           fluid, causing hyponatraemia and tissue congestion.   myoglobin-induced toxic nephropathy. Alkalisation
           Volume overload may result in systemic and pulmo-  This is probably achieved with better solubility
           nary oedema.                                   of  myoglobin  in  the  alkaline  medium.  Therefore,
             Mannitol has been used for prophylaxis against   horses affected by rhabdomyolysis benefit from
           renal dysfunction; however, the benefit of its admin-  bicarbonate administration.
           istration is questionable. Mannitol is contraindicated
           in patients with anuria secondary to renal disease,  Other drugs
           severe dehydration, pulmonary congestion and con-  Cisplatin, a chemotherapy medication for vari-
           gestive heart failure. Numerous studies confirmed   ous solid tumours, has dose-dependent side-effects
           the nephrotoxic potential of high-dose mannitol.   on the kidney. Oxidative stress, DNA damage and
           This has not been reported or investigated in horses.   inflammation induce renal damage. In human medi-
                                                          cine one-third of patients who have undergone
           Furosemide                                       cisplatin  therapy  develop  nephrotoxicity  despite
           Furosemide is a loop diuretic that blocks the neph-    adequate pre-hydration. This has not yet been
           ron site responsible for urinary concentration and   reported in horses.
           increases urinary water, sodium, potassium, calcium   Proton pump inhibitors are widely used in equine
           and magnesium excretion. Loop diuretics may cause   medicine. In humans they have been linked to acute
           electrolyte disturbances such as hypokalaemia, hypo-  interstitial nephritis and CKD. Renal toxicity may
           calcaemia, hypomagnesaemia, metabolic alkalosis   be through a cell-mediated idiosyncratic immune
           and volume contraction. Furosemide can be useful   response with diffuse interstitial leucocyte infil-
           in patients with renal insufficiency. However, fac-  trate (interstitial nephritis). Impaired renal func-
           tors that limit proximal tubule secretory activity (e.g.   tion was also reported in horses based on serum
           decreased  renal  blood  flow or renal failure)  reduce   urea and creatinine levels. Proton pump inhibitors
           the effectiveness of furosemide and other diuretics.  (omeprazole) should therefore be used with cau-
             NSAIDs diminish the response to loop and thia-  tion in horses with pre-existing kidney disease.
           zide diuretics because they increase electrolyte and   Regular urine and blood analyses should be carried
           water resorption at the thick ascending limb of the   out in horses treated chronically with proton pump
           loop of Henle. Concomitant use of furosemide and   inhibitors.
           aminoglycosides may produce severe ototoxicity,   Ammonium chloride (60–520 mg/kg p/o q24 h),
           especially in young animals.                   ammonium sulphate (175 mg/kg p/o q24 h), and
             Furosemide should be used cautiously in sep-  ascorbic acid (1–2 g/kg p/o q24 h) are used for urine
           tic patients, because it can trigger a pronounced   acidification. Horses do not find ammonium salts
           decrease in  medullary  blood  flow  and consequent   palatable and will rarely voluntarily ingest the vol-
           medullar ischaemia. These alterations in blood flow   ume required to acidify urine.
           were not evident in non-septic cases.            Phenoxybenzamine (0.7 mg/kg p/o q6 h), an
                                                          alpha-adrenergic  blocker,  can  be  used  to  diminish
           Dopamine                                       urethral resistance in UMN bladder dysfunction.
           The use of dopamine may improve renal blood flow   Bethanecol chloride (0.025–0.075 mg/kg s/c q8 h)
           in horses with AKI. Dopamine dilates renal arte-  exerts stimulatory effects on the smooth muscle of
           rioles and increases renal blood flow and the GFR.   the bladder. It is a drug of choice in cases of detrusor
           Cardiac dysrhythmias are the most common adverse   atony. Side-effects include abdominal discomfort,
           effects recognised in horses.                  excessive salivation and lacrimation.
   980   981   982   983   984   985   986   987   988   989   990